Biome Australia Anticipates International Sales Revenue to Grow 85% in Fiscal 2024; Shares Down 4%
Biome Australia (ASX:BIO) is expecting double-digit growth in sales revenue from international markets following its launch in the UK and Ireland early this year, with the company eyeing Western Europ
Biome Looking Healthy as Sales Send Shares Soaring
Biome’s (ASX: BIO) shares were up 17% in early trade as the microbiome health company reported 85% growth in international sales.
Biome Australia Logs 74% Revenue Increase in Fiscal Q3
Biome Australia (ASX:BIO) logged AU$3.2 million in revenue in the fiscal third quarter ended March 31, a 74% jump from the same period a year prior, according to a Thursday filing with the Australian
Biome Australia Logs First Positive Underlying Quarterly Cash Flow in Fiscal Q3
Biome Australia (ASX:BIO) posted its first positive underlying quarterly cash flow in the third quarter of fiscal 2024, the microbiome health company said in a Tuesday filing with the Australian Secur
Biome Australia to Launch Into UK and Ireland Health Retail Markets
Biome Australia (ASX:BIO) has started delivering its first allocation of Activated Probiotics into pharmacy and health retail stores across the United Kingdom and the Republic of Ireland.
Biome's Activated Probiotics Enters UK, Ireland; Shares Jump 10%
Microbiome health company Biome Australia (ASX:BIO) has delivered its first allocation of Activated Probiotics into UK and Republic of Ireland pharmacy and health retail stores following the signing o
Biome Australia Lifts FY24 Revenue Guidance to $12.5m
Specialist live biotherapeutics health company Biome Australia (ASX: BIO) has significantly increased its full year revenue guidance to $12.5 million, boosted by better-than-expected sales in recent months.
Biome Reports Surge in Half Year Sales Revenue
Biome Australia (ASX:BIO) said it recorded unaudited sales revenue of approximately AU$6 million for the first half of FY24 and unaudited sales revenue of approximately AU$3.3 million for the second q
Australian Shares Slide as Rate Cut Hopes Lose Steam
Australian shares declined on Thursday as optimism for rate cuts ran out of steam amid an overbought market. The S&P/ASX 200 Index was down 33.80 points, or 0.5%, to 7,504.10. Equities had an aggressi
Biome Australia to Launch Cholesterol-Lowering Probiotic; Shares Climb 6%
Biome Australia (ASX:BIO) will launch a cholesterol-lowering probiotic, Biome Cholesterol Probiotic, in the fiscal fourth quarter of 2024. The product comprises three specific Lactobacillus plantarum
Biome Australia Logs Record Q1 Sales
Biome Australia (ASX:BIO) reported record sales of AU$2.74 million for the first quarter of FY 2024, which surpassed the firm's target of AU$2.5 shared with the market in July. The historic figure for
Biome Australia (ASX:BIO) Reports "Positive" Pre-publication Results in Biome Lift Trial
Biome Australia Records 75% Jump in Fiscal 2023 Revenue
Biome Australia (ASX:BIO) posted a 75% year-on-year jump in revenue to AU$7.2 million in fiscal 2023.
Biome Australia (ASX:BIO) Surpasses $7m Sales Revenue Target
Biome (ASX:BIO) Doubles Quarterly Sales Revenue in Q3 FY23
No Data